Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arnfinn Engeset is active.

Publication


Featured researches published by Arnfinn Engeset.


Immunology Letters | 1983

Rat liver contains a distinct blood-borne population of NK cells resistant to anti-asialo-GM1 antiserum.

Barbara Lukomska; W. Olszewski; Arnfinn Engeset

A high level of anti-tumoral (NK) cytotoxicity was observed in the mononuclear population washed out from the liver microvasculature in rat. The level of cytotoxicity against K562 and YAC1 cells, percentage of large granular lymphocytes (LGL) and of OX8+ cells was significantly higher than in the inflowing portal and also caval blood. A low concentration of adherent, phagocytic and OX6+(Ia) cells and a higher level of cytotoxicity after removal of adherent cells ruled out the possibility of liver macrophages to be responsible for the cytotoxicity. Surprisingly, the liver-sequestered NK population turned to be resistant to anti-asialo-GM1 antiserum. Thus, liver microvasculature contains a significant number of cells with characteristics of NK cells which constitute a functionally distinct NK population.


Chemotherapy | 1986

Pharmacokinetics of Oral Co-Trimazine and the Penetration of Its Components Sulfadiazine and Trimethoprim into Peripheral Human Lymph

Tom Bergan; Arnfinn Engeset; W. Olszewski

Five healthy informed male volunteers received oral doses of 820 mg sulfadiazine (SDZ) plus 180 mg trimethoprim (TMP) (co-trimazine) every 24 h. Concentrations in serum, peripheral lymph from the leg and urine were determined after the first dose, and on the 4th day to reflect approximate steady-state conditions. TMP was assayed microbiologically and unchanged SDZ by high-pressure liquid chromatography. There was a rise in concentrations from the first dose to the 4th day. The rise for SDZ was by a factor of 1.6 in both serum and lymph; the rise for TMP was also 1.6 in serum, but 1.5 in lymph. The peak concentrations at steady state were 27.7 mg/l (SD) +/- 4.3 SDZ, and 1.6 +/- 0.68 mg/l TMP. The serum values at that time were 31.7 +/- 5.8 mg/l SDZ and 2.3 +/- 0.51 mg/l TMP. The simultaneous concentrations of both SDZ and TMP were always somewhat lower in lymph than in serum, also at the end of the observation periods, i.e. 12 h after the first dose and 72 h after the final one. But the serum concentrations of both SDZ and TMP were only slightly higher than in lymph. After the final dose, the ratio between the 12-hour areas under the concentration curves of lymph and serum was 0.68 +/- 0.12 for SDZ and 0.59 +/- 0.14 for TMP. The values after the first dose were similar, 0.63 +/- 0.17 and 0.57 +/- 0.05, respectively. The elimination half-life in serum during steady state was 16.5 h for SDZ, 8.6 h for acetylated SDZ and 9.4 h for TMP. In lymph the corresponding values were 19.2, 19.2 and 8.9 h.


Drugs | 1985

Temocillin Penetration of Peripheral Lymph

Tom Bergan; W. Olszewski; Arnfinn Engeset

SummaryAn intravenous dose of temocillin 1g was administered to 5 healthy human volunteers from whom peripheral lymph, serum and urine were monitored for 12 hours. The concentrations after 1 hour were 14.3 mg/L in lymph and 58.1 mg/L in serum. The mean peak concentration in lymph (appearing between 1.5 and 2 hours) was 30.6 mg/L, and the simultaneous serum level was 47.8 mg/L. The lymph concentrations were always below those in serum, and the elimination half life was 4.4 hours from lymph compared wth 4.9 hours from serum. The ratio between the total areas under the concentration curves in lymph and in serum was 0.56, which reflects the ability of temocillin to penetrate to lymph. Serum protein binding appeared to impede the rate of transport from serum to lymph, but when compared with the results of less highly bound penicillins the total penetration of temocillin was better than expected.


Clinical Infectious Diseases | 1987

Does serum protein binding inhibit tissue penetration of antibiotics

Tom Bergan; Arnfinn Engeset; Waldemar L. Olszewski


Clinics in Dermatology | 1995

Immune cell traffic from blood through the normal human skin to lymphatics.

Waldemar L. Olszewski; I. Grzelak; Anna Ziolkowska; Arnfinn Engeset


Journal of Surgical Oncology | 1989

Effect of local hyperthermia on lymph immune cells and lymphokines of normal human skin

Waldemar L. Olszewski; I. Grzelak; Anna Ziolkowska; Arnfinn Engeset


Journal of Antimicrobial Chemotherapy | 1983

Temocillin in peripheral lymph

Tom Bergan; Arnfinn Engeset; W. Olszewski


Journal of Antimicrobial Chemotherapy | 1982

Penetration of erythromycin into human peripheral lymph

Tom Bergan; Arnfinn Engeset; W. Olszewski; Kenneth Josefsson; Nannkeke Laesen


Journal of Antimicrobial Chemotherapy | 1986

Penetration to peripheral human lymph of clavulanic acid and ticarcillin

Tom Bergan; W. Olszewski; Arnfinn Engeset


Journal of Antimicrobial Chemotherapy | 1983

Distribution to human peripheral lymph of amoxycillin and of ampicillin from the oral prodrug bacampicillin

Tom Bergan; Arnfinn Engeset; W. Olszewski; Jan Sjövall

Collaboration


Dive into the Arnfinn Engeset's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Ziolkowska

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

I. Grzelak

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Lukomska

Polish Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge